Sponsor Pipeline

Shanghai Pharmaceuticals Holding Co., Ltd Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
14
Active Trials
13
Recruiting
2
Phase 3
4
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-07 NCT05944224
A Study to Efficacy and Safety of SPH4336 Monotherapy or in Combination With Cadonilimab…
date change Primary completion pushed: 2026-05-31 -> 2026-12-31
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-08-10 NCT07754825 A Phase II Clinical Study of LT3001 for Injection in the Treatment of Acute Ischemic… Phase 2 Not Yet Recruiting
Active Trials by Phase
Phase 2/3
2
Phase 2
4
Phase 1/2
3
Phase 1
2
Early Phase 1
3
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT05744687 Phase II/III Study of SPH4336 Combined With Letrozole vs Placebo Combined With Letrozole… Locally Advanced or Metastatic Breast Cancer Recruiting
NCT05860465 Safety and Efficacy of SPH4336 in Combination With Endocrine Therapy in the Treatment of… Locally Advanced or Metastatic Breast Cancer Recruiting
Phase 2
NCT06434597 A Clinical Study of SPH5030 Tablets in the Treatment of Her2-positive/Mutated Biliary… Biliary Tract or Colorectal Cancer With Her2-positive/Mutated Recruiting
NCT05686642 Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke Acute Ischemic Stroke Recruiting
NCT05872347 Efficacy and Safety of SPH4336 in Combination With Endocrine Therapy in Breast Cancer… Breast Cancer Brain Metastases Recruiting
NCT07754825 A Phase II Clinical Study of LT3001 for Injection in the Treatment of Acute Ischemic… Acute Ischemic Stroke Not Yet Recruiting
Phase 1/2
NCT06214143 A Clinical Study of T3011 in Combination With PD-1/PD-L1 Inhibitors in Subjects With… Advanced Solid Tumors Recruiting
NCT05944224 A Study to Efficacy and Safety of SPH4336 Monotherapy or in Combination With Cadonilimab… Advanced Solid Tumors Recruiting
NCT06214156 A Clinical Study of T3011 in Subjects With Advanced Melanoma Advanced Melanoma Recruiting
Phase 1
NCT06487455 A Clinical Study of SPH7485 Tablets in the Treatment of Advanced Solid Tumors. Advanced Solid Tumor Recruiting
NCT06839131 A Clinical Study of SPH9788 Tablets in Healthy Chinese Subjects. Healthy Participants Recruiting
Early Phase 1
NCT05145361 Clinical Study of B001 Injection in Subjects With Neuromyelitis Optic Spectrum Disorder… NMO Spectrum Disorder Recruiting
NCT05245058 SPH5030 Tablets in Subjects With Advanced Her2-positive Solid Tumors HER2-positive Advanced Solid Tumors Recruiting
NCT06483373 A Clinical Study of SPH7854 Granules in Healthy Subjects. Inflammatory Bowel Disease Recruiting
Disease Areas
Get alerts when Shanghai Pharmaceuticals Holding Co., Ltd's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free